Stay up to date on the latest in diabetes therapy and earn CE credits. This year's program features the following presentations:
"Obesity and Diabetes: Medications for Obesity" -Caroline Apovian, MD
"Medical Marijuana and CBD Use in Diabetes" -Kam Capoccia, PharmD, BCPS, CDCES
"Helping People with Diabetes Shift Their Mindset and Change Their Approach to Self-Care Behaviors" -Mark Heyman, PhD, CDCES
Purpose
This seminar is being offered to provide up-to-date information on the medications used to treat obesity in patients with diabetes, the use of medical marijuana and CDB in diabetes, and practical approaches to help patients with diabetes through self-care behaviors.
Target Audience
Certified Diabetes Outpatient Educators (CDOE), registered dietitians, registered nurses, registered pharmacists, nurse practitoners, and other allied health professionals interested in the management and research of diabetes and chronic disease.
Continuing Education Credits
This program has been submitted for 4.0 LIVE contact hours through the Northeast Multi-State Division (NE-MSD) Association. NE-MSD is an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. Participants must attend the entire symposium and complete a written evaluation to be awarded continuing education credits.
The University of Rhode Island College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This is a knowledge-based educational activity. Pharmacists will receive 4.0 LIVE contact hours (0.4 CEUs) for the educational activity. Participants must attend the entire symposium and complete an online evaluation to be awarded continuing education credits. No partial credit is available.
UAN: 0060-9999-22-032-L01-P
Program Agenda
| |
Saturday, April 30, 2022 |
|
| 7:00-8:00am |
Exhibit Hall Break Out Sessions |
|
| 8:05-8:10am |
Welcoming Remarks |
Cynthia Silvia, MSN, RN, CDOE |
| 8:10-9:40am |
"Obesity and Diabetes: Medications for Obesity" |
Caroline Apovian, MD
|
| 9:40-10:20am |
Exhibit Hall Break Out Sessions |
|
| 10:25-11:40am |
"Medical Marijuana and CBD Use in Diabetes" |
Kam Capoccia, PharmD, BCPS, CDCES
|
| 11:40am-12:55pm |
"Helping People with Diabetes Shift Their Mindset and Change Their Approach to Self-Care Behaviors" |
Mark Heyman, PhD, CDCES
|
|
12:55-1:00pm
|
Closing Remarks/Adjourn
|
Cynthia Silvia, RN, MSN, CDOE
|
Learning Objectives
Obesity and Diabetes: Medications for Obesity
Caroline M. Apovian, MD, FACN, FACP, FTOS, DABOM
1. Describe the relationship between obesity and diabetes
2. Discuss the BMI criteria for which practitioners can recommend Anti-Obesity
Medications (AOM)
3. Describe the treatment recommended in the 2019 ADA Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes, for individuals with diabetes and with obesity
4. Describe the effectiveness of anti-obesity medications
5. Discuss the newest FDA-approved AOM and its mechanism of action
Medical Marijuana and CBD Use in Diabetes
Kam Capoccia, PharmD, BCPS, CDCES
1. Describe medical marijuana and cannabidiol (CBD) with respect to the known
pharmacologic properties
2. Discuss the literature regarding the use of medical marijuana and CBD in people with diabetes
3. Describe the role of the diabetes educator in assessing the use of medical marijuana and CBD
Helping People With Diabetes Shift Their Mindset and Change Their Approach to Self-Care Behaviors
Mark Heyman, PhD, CDCES
1. Describe common psychosocial barriers to diabetes management
2. Describe how diabetes care and education specialists can help people reduce
psychosocial and behavioral barriers to diabetes management
3. Discuss interventions to address psychosocial barriers in diabetes management in practices
